Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

936 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.
Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, Burst V, Grundmann F, Jadoul M, Szombati I, Tesař V, Segelmark M, Potarca A, Schall TJ, Bekker P; CLEAR Study Group. Jayne DRW, et al. Among authors: harper l. J Am Soc Nephrol. 2017 Sep;28(9):2756-2767. doi: 10.1681/ASN.2016111179. Epub 2017 Apr 11. J Am Soc Nephrol. 2017. PMID: 28400446 Free PMC article. Clinical Trial.
ANCA-positive vasculitis.
Kamesh L, Harper L, Savage CO. Kamesh L, et al. Among authors: harper l. J Am Soc Nephrol. 2002 Jul;13(7):1953-60. doi: 10.1097/01.asn.0000016442.33680.3e. J Am Soc Nephrol. 2002. PMID: 12089393 Review. No abstract available.
Anti-neutrophil cytoplasm-associated glomerulonephritis.
Morgan MD, Harper L, Williams J, Savage C. Morgan MD, et al. Among authors: harper l. J Am Soc Nephrol. 2006 May;17(5):1224-34. doi: 10.1681/ASN.2005080882. Epub 2006 Apr 19. J Am Soc Nephrol. 2006. PMID: 16624931 Review.
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D'Cruz D, Guillevin L, Harper L, Jayne D, Luqmani R, Mooney J, Scott D; BSR and BHPR Standards, Guidelines and Audit Working Group. Lapraik C, et al. Among authors: harper l. Rheumatology (Oxford). 2007 Oct;46(10):1615-6. doi: 10.1093/rheumatology/kem146a. Epub 2007 Sep 5. Rheumatology (Oxford). 2007. PMID: 17804455 No abstract available.
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO; EUVAS (European Vasculitis Study Group). de Groot K, et al. Among authors: harper l. Ann Intern Med. 2009 May 19;150(10):670-80. doi: 10.7326/0003-4819-150-10-200905190-00004. Ann Intern Med. 2009. PMID: 19451574 Clinical Trial.
Adverse effects of therapy for ANCA-associated vasculitis.
Turnbull J, Harper L. Turnbull J, et al. Among authors: harper l. Best Pract Res Clin Rheumatol. 2009 Jun;23(3):391-401. doi: 10.1016/j.berh.2009.04.002. Best Pract Res Clin Rheumatol. 2009. PMID: 19508946 Review.
936 results